Aim: To investigate the effect of body mass index (BMI) on the current control of HbA1c (A), blood pressure (B) and cholesterol(C) in patients with type 2 diabetes (T2D) from Tibet based on electronic medical records.

Methods: Patients aged 18-79 years with T2D documented from 2014 to 2018 were enrolled in this study. Control criteria were defined base on the 2017 Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes: HbA1c < 7.0%, blood pressure < 130/80mmHg and low-density lipoprotein-Cholesterol (LDL-C) < 1.8 mmol/L with coronary heart disease (CHD) and 2.6 mmol/L without CHD. Patients were divided into three groups according to BMI. One-way ANOVA and Chi-square tests were used to compare differences among groups.

Results: A total of 1999 patients were included in the study. The mean (SD) age was 55.2 (10.5) years. The median diabetic duration was 7.0 (range: 0.1-32) years and 879 (43.9%) patients were female. Among the three groups, patients with obesity had the worst metabolic profile with the highest systolic blood pressure, diastolic blood pressure and LDL-C. The achievement of ABC control has worsened in parallel with increasing BMI (Table).

Conclusions: Higher BMI was associated with lower ABC control of diabetes. More intensive weight management is warranted in this population.


Z. Chenghui: None. L. Mingxia: None. W. Suyuan: None. W. Yunhong: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at